世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000032261

婦人科癌治療薬の世界市場(2022-2026)

TechNavio

Global Gynecological Cancers Therapeutics Market 2022-2026

発刊日 2022/05/29

言語英語

体裁PDF/120ページ

ライセンス/価格120ページ

0000032261

Single
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

本レポートは、婦人科癌治療薬市場を分析します。

世界の婦人科癌治療薬市場は、予測期間中に約14.67 %のCAGRで推移し、2022年から2026年の間に142億2,000万USドルの成長が見込まれています。本レポートは、総体的な分析、市場規模と予測、動向、成長推進要因、課題、および約25社のベンダーを対象とするベンダー分析を提供しています。

本レポートは、現在の世界市場シナリオ、最新動向と成長推進要因、および全体的な市場環境に関する最新の分析を提供します。市場を牽引しているのは、婦人系癌の罹患率の増加、強力なパイプラインと新薬の承認、患者支援プログラムの増加などです。

調査範囲

  • 市場セグメント
    ➣ タイプ別
      ◇ 子宮癌
      ◇ 卵巣癌
      ◇ 子宮頸癌
      ◇ その他
    ➣ 地域別
      ◇ 北アメリカ
      ◇ ヨーロッパ
      ◇ アジア
      ◇ その他の地域

本調査では、新規治療法の出現が、今後数年間の婦人科癌治療薬市場の成長を促進する主要な理由の1つであると特定しています。また、高度な診断方法の利用可能性と婦人科癌に対する意識の高まりが、同市場における大きな需要につながるでしょう。

TechNavio社は、主要なパラメーターの分析による複数のソースからのデータの調査、合成、および合計によって、市場の詳細な状況を提示します。

本レポートは以下の分野をカバーしています。

  • 婦人科癌治療薬の市場規模
  • 婦人科癌治療薬の市場予測
  • 婦人科癌治療薬市場の業界分析

TechNavio社の堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されており、これに沿って、主要な婦人科癌治療薬市場ベンダーの詳細な分析を提供します

  • 調査企業
    ➣ AbbVie Inc.
    ➣ Amgen Inc.
    ➣ AstraZeneca Plc
    ➣ Becton Dickinson and Co.
    ➣ Biocon Ltd.
    ➣ Bristol Myers Squibb Co.
    ➣ Clovis Oncology Inc.
    ➣ 第一三共(Daiichi Sankyo Co. Ltd.)
    ➣ Eli Lilly and Co.
    ➣ F. Hoffmann La Roche Ltd.
    ➣ GlaxoSmithKline Plc
    ➣ ImmunoGen Inc.
    ➣ Johnson and Johnson
    ➣ Karyopharm Therapeutics Inc.
    ➣ Merck and Co. Inc.
    ➣ Novartis AG
    ➣ Pfizer Inc.
    ➣ Sanofi
    ➣ Siemens Healthcare GmbH
    ➣ Teva Pharmaceutical Industries Ltd.

また、本レポートには、市場の成長に影響を与える今後の動向と課題に関する情報が含まれており、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。

この調査は、業界の主要な参加者からの情報を含む、一次情報と二次情報の客観的な組み合わせを使用して実施されました。本レポートには、主要ベンダーの分析に加えて、包括的な市場とベンダー情勢が含まれています。

TechNavio社について

TechNavio社は、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析により、複数のソースからのデータの調査、統合、および集計により、市場の詳細な状況を提示します。また、業界の主要なインフルエンサーを特定することにより、さまざまな市場の側面を提示します。提示されたデータは、包括的で信頼性が高く、一次および二次の広範な調査の結果です。TechNavio社の市場調査レポートは、完全な競争環境と、質的および量的調査を使用して正確な市場成長を予測する詳細なベンダー選択の調査手法と分析を提供します。

レポート詳細

目次

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis
4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Type
5.1 Market segments
Exhibit 24: Chart on Type - Market share 2021-2026 (%)
Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
5.2 Comparison by Type
Exhibit 26: Chart on Comparison by Type
Exhibit 27: Data Table on Comparison by Type
5.3 Uterine cancer - Market size and forecast 2021-2026
Exhibit 28: Chart on Uterine cancer - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Uterine cancer - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Uterine cancer - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Uterine cancer - Year-over-year growth 2021-2026 (%)
5.4 Ovarian cancer - Market size and forecast 2021-2026
Exhibit 32: Chart on Ovarian cancer - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Ovarian cancer - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Ovarian cancer - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Ovarian cancer - Year-over-year growth 2021-2026 (%)
5.5 Cervical cancer - Market size and forecast 2021-2026
Exhibit 36: Chart on Cervical cancer - Market size and forecast 2021-2026 ($ million)
Exhibit 37: Data Table on Cervical cancer - Market size and forecast 2021-2026 ($ million)
Exhibit 38: Chart on Cervical cancer - Year-over-year growth 2021-2026 (%)
Exhibit 39: Data Table on Cervical cancer - Year-over-year growth 2021-2026 (%)
5.6 Others - Market size and forecast 2021-2026
Exhibit 40: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibit 41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibit 42: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibit 43: Data Table on Others - Year-over-year growth 2021-2026 (%)
5.7 Market opportunity by Type
Exhibit 44: Market opportunity by Type ($ million)

6 Customer Landscape
6.1 Customer landscape overview
Exhibit 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape
7.1 Geographic segmentation
Exhibit 46: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 48: Chart on Geographic comparison
Exhibit 49: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 50: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 66: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 China - Market size and forecast 2021-2026
Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
7.9 Germany - Market size and forecast 2021-2026
Exhibit 74: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
7.10 Canada - Market size and forecast 2021-2026
Exhibit 78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 80: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
7.11 UK - Market size and forecast 2021-2026
Exhibit 82: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 83: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 84: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 85: Data Table on UK - Year-over-year growth 2021-2026 (%)
7.12 Market opportunity By Geographical Landscape
Exhibit 86: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends
8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 87: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends

9 Vendor Landscape
9.1 Overview
9.2 Vendor landscape
Exhibit 88: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 89: Overview on factors of disruption
9.4 Industry risks
Exhibit 90: Impact of key risks on business

10 Vendor Analysis
10.1 Vendors covered
Exhibit 91: Vendors covered
10.2 Market positioning of vendors
Exhibit 92: Matrix on vendor position and classification
10.3 AbbVie Inc.
Exhibit 93: AbbVie Inc. - Overview
Exhibit 94: AbbVie Inc. - Product / Service
Exhibit 95: AbbVie Inc. - Key offerings
10.4 Amgen Inc.
Exhibit 96: Amgen Inc. - Overview
Exhibit 97: Amgen Inc. - Product / Service
Exhibit 98: Amgen Inc. - Key offerings
10.5 AstraZeneca Plc
Exhibit 99: AstraZeneca Plc - Overview
Exhibit 100: AstraZeneca Plc - Product / Service
Exhibit 101: AstraZeneca Plc - Key news
Exhibit 102: AstraZeneca Plc - Key offerings
10.6 Bristol Myers Squibb Co.
Exhibit 103: Bristol Myers Squibb Co. - Overview
Exhibit 104: Bristol Myers Squibb Co. - Product / Service
Exhibit 105: Bristol Myers Squibb Co. - Key offerings
10.7 Clovis Oncology Inc.
Exhibit 106: Clovis Oncology Inc. - Overview
Exhibit 107: Clovis Oncology Inc. - Business segments
Exhibit 108: Clovis Oncology Inc. - Key offerings
Exhibit 109: Clovis Oncology Inc. - Segment focus
10.8 Daiichi Sankyo Co. Ltd.
Exhibit 110: Daiichi Sankyo Co. Ltd. - Overview
Exhibit 111: Daiichi Sankyo Co. Ltd. - Business segments
Exhibit 112: Daiichi Sankyo Co. Ltd. - Key news
Exhibit 113: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibit 114: Daiichi Sankyo Co. Ltd. - Segment focus
10.9 Eli Lilly and Co.
Exhibit 115: Eli Lilly and Co. - Overview
Exhibit 116: Eli Lilly and Co. - Product / Service
Exhibit 117: Eli Lilly and Co. - Key offerings
10.10 F. Hoffmann La Roche Ltd.
Exhibit 118: F. Hoffmann La Roche Ltd. - Overview
Exhibit 119: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 120: F. Hoffmann La Roche Ltd. - Key news
Exhibit 121: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 122: F. Hoffmann La Roche Ltd. - Segment focus
10.11 GlaxoSmithKline Plc
Exhibit 123: GlaxoSmithKline Plc - Overview
Exhibit 124: GlaxoSmithKline Plc - Business segments
Exhibit 125: GlaxoSmithKline Plc - Key news
Exhibit 126: GlaxoSmithKline Plc - Key offerings
Exhibit 127: GlaxoSmithKline Plc - Segment focus
10.12 Merck and Co. Inc.
Exhibit 128: Merck and Co. Inc. - Overview
Exhibit 129: Merck and Co. Inc. - Business segments
Exhibit 130: Merck and Co. Inc. - Key news
Exhibit 131: Merck and Co. Inc. - Key offerings
Exhibit 132: Merck and Co. Inc. - Segment focus

11 Appendix
11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 133: Inclusions checklist
Exhibit 134: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 135: Currency conversion rates for US$
11.4 Research methodology
Exhibit 136: Research methodology
Exhibit 137: Validation techniques employed for market sizing
Exhibit 138: Information sources
11.5 List of abbreviations
Exhibit 139: List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Vendor Market Positioning
Exhibits9: Parent market
Exhibits10: Market Characteristics
Exhibits11: Offerings of vendors included in the market definition
Exhibits12: Market segments
Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
Exhibits17: Five forces analysis - Comparison between 2021 and 2026
Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
Exhibits23: Chart on Market condition - Five forces 2021 and 2026
Exhibits24: Chart on Type - Market share 2021-2026 (%)
Exhibits25: Data Table on Type - Market share 2021-2026 (%)
Exhibits26: Chart on Comparison by Type
Exhibits27: Data Table on Comparison by Type
Exhibits28: Chart on Uterine cancer - Market size and forecast 2021-2026 ($ million)
Exhibits29: Data Table on Uterine cancer - Market size and forecast 2021-2026 ($ million)
Exhibits30: Chart on Uterine cancer - Year-over-year growth 2021-2026 (%)
Exhibits31: Data Table on Uterine cancer - Year-over-year growth 2021-2026 (%)
Exhibits32: Chart on Ovarian cancer - Market size and forecast 2021-2026 ($ million)
Exhibits33: Data Table on Ovarian cancer - Market size and forecast 2021-2026 ($ million)
Exhibits34: Chart on Ovarian cancer - Year-over-year growth 2021-2026 (%)
Exhibits35: Data Table on Ovarian cancer - Year-over-year growth 2021-2026 (%)
Exhibits36: Chart on Cervical cancer - Market size and forecast 2021-2026 ($ million)
Exhibits37: Data Table on Cervical cancer - Market size and forecast 2021-2026 ($ million)
Exhibits38: Chart on Cervical cancer - Year-over-year growth 2021-2026 (%)
Exhibits39: Data Table on Cervical cancer - Year-over-year growth 2021-2026 (%)
Exhibits40: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibits41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibits42: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibits43: Data Table on Others - Year-over-year growth 2021-2026 (%)
Exhibits44: Market opportunity by Type ($ million)
Exhibits45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits46: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibits47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
Exhibits48: Chart on Geographic comparison
Exhibits49: Data Table on Geographic comparison
Exhibits50: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibits51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibits52: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibits53: Data Table on North America - Year-over-year growth 2021-2026 (%)
Exhibits54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibits56: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibits57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
Exhibits58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibits60: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibits61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
Exhibits62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibits64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibits66: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibits67: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibits68: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibits69: Data Table on US - Year-over-year growth 2021-2026 (%)
Exhibits70: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibits71: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibits72: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibits73: Data Table on China - Year-over-year growth 2021-2026 (%)
Exhibits74: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits75: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibits76: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibits77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
Exhibits78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibits80: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibits81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
Exhibits82: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibits83: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibits84: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibits85: Data Table on UK - Year-over-year growth 2021-2026 (%)
Exhibits86: Market opportunity By Geographical Landscape ($ million)
Exhibits87: Impact of drivers and challenges in 2021 and 2026
Exhibits88: Overview on Criticality of inputs and Factors of differentiation
Exhibits89: Overview on factors of disruption
Exhibits90: Impact of key risks on business
Exhibits91: Vendors covered
Exhibits92: Matrix on vendor position and classification
Exhibits93: AbbVie Inc. - Overview
Exhibits94: AbbVie Inc. - Product / Service
Exhibits95: AbbVie Inc. - Key offerings
Exhibits96: Amgen Inc. - Overview
Exhibits97: Amgen Inc. - Product / Service
Exhibits98: Amgen Inc. - Key offerings
Exhibits99: AstraZeneca Plc - Overview
Exhibits100: AstraZeneca Plc - Product / Service
Exhibits101: AstraZeneca Plc - Key news
Exhibits102: AstraZeneca Plc - Key offerings
Exhibits103: Bristol Myers Squibb Co. - Overview
Exhibits104: Bristol Myers Squibb Co. - Product / Service
Exhibits105: Bristol Myers Squibb Co. - Key offerings
Exhibits106: Clovis Oncology Inc. - Overview
Exhibits107: Clovis Oncology Inc. - Business segments
Exhibits108: Clovis Oncology Inc. - Key offerings
Exhibits109: Clovis Oncology Inc. - Segment focus
Exhibits110: Daiichi Sankyo Co. Ltd. - Overview
Exhibits111: Daiichi Sankyo Co. Ltd. - Business segments
Exhibits112: Daiichi Sankyo Co. Ltd. - Key news
Exhibits113: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibits114: Daiichi Sankyo Co. Ltd. - Segment focus
Exhibits115: Eli Lilly and Co. - Overview
Exhibits116: Eli Lilly and Co. - Product / Service
Exhibits117: Eli Lilly and Co. - Key offerings
Exhibits118: F. Hoffmann La Roche Ltd. - Overview
Exhibits119: F. Hoffmann La Roche Ltd. - Business segments
Exhibits120: F. Hoffmann La Roche Ltd. - Key news
Exhibits121: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits122: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits123: GlaxoSmithKline Plc - Overview
Exhibits124: GlaxoSmithKline Plc - Business segments
Exhibits125: GlaxoSmithKline Plc - Key news
Exhibits126: GlaxoSmithKline Plc - Key offerings
Exhibits127: GlaxoSmithKline Plc - Segment focus
Exhibits128: Merck and Co. Inc. - Overview
Exhibits129: Merck and Co. Inc. - Business segments
Exhibits130: Merck and Co. Inc. - Key news
Exhibits131: Merck and Co. Inc. - Key offerings
Exhibits132: Merck and Co. Inc. - Segment focus
Exhibits133: Inclusions checklist
Exhibits134: Exclusions checklist
Exhibits135: Currency conversion rates for US$
Exhibits136: Research methodology
Exhibits137: Validation techniques employed for market sizing
Exhibits138: Information sources
Exhibits139: List of abbreviations

この商品のレポートナンバー

0000032261

TOP